Baker McKenzie Guides Servier On $2.5B Oncology Deal
French pharmaceutical group Servier said Friday that it has agreed to acquire Day One for about $2.5 billion in cash, with legal guidance from Baker McKenzie....To view the full article, register now.
Already a subscriber? Click here to view full article